CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO RULE 24B-2
Certain portions, indicated by [*****], of this exhibit have been omitted pursuant to Rule 24b-2 of the Securities Act of
1934. The omitted materials have been filed separately with Securities and Exchange Commission.
TISSUE RECOVERY AGREEMENT
THIS TISSUE RECOVERY AGREEMENT (this “Agreement”), effective on this 21st day of January, 2005 (“Effective Date”),
is by and between Regeneration Technologies, Inc., a Delaware corporation having its principal place of business at 11621
Research Circle, Alachua, Florida (“RTI”), and Southeast Tissue Alliance, Inc., a Florida not-for-profit corporation having its
principal place of business at 6241 NW 23rd Street, Suite 400, Gainesville, Florida (“SETA”).
WHEREAS, RTI and SETA were parties to that certain agreement entitled, the “Tissue Recovery Agreement” made and
entered into by the parties effective as April 15, 1999, and as amended by letters dated January 19, 2001, and December 19, 2001;
(the “Previous Agreement”) attached hereto as Exhibit “A”; and
WHEREAS, the parties wish to replace the Previous Agreement with this Agreement; and
WHEREAS, RTI recovers and processes human donor tissue and has arrangements with third parties to distribute the
resulting allograft tissue for implant surgeries throughout the world; and
WHEREAS, SETA desires to recover and provide human tissue to RTI for processing allograft tissue and for conducting
research, and both parties desire to cooperate to increase the amount of human tissue available for the production by RTI and
distribution of allograft tissue.
NOW, THEREFORE, in view of the representations made above and in consideration of the terms and conditions set forth
below, the parties agree as follows:
ARTICLE I -General Obligations
1.1 Upon the effective date of this Agreement the parties acknowledge that the Previous Agreement has been terminated,
except that indemnificat